Nanomaterial-based aptasensors as an efficient substitute for cardiovascular disease diagnosis: Future of smart biosensors

Abdelmonaim Azzouz,Lamia Hejji,Christian Sonne,Ki-Hyun Kim,Vanish Kumar

DOI: https://doi.org/10.1016/j.bios.2021.113617

IF: 12.545

2021-12-01

Biosensors and Bioelectronics

Abstract:As a major cause of deaths in developed countries, cardiovascular diseases (CVD) are a steadily growing burden for health systems. In particular, early and rapid detection of CVD is important for on time appropriate therapy so as to reduce the mortality rate. Aptamers, known as single-stranded DNA/RNA or oligonucleotides containing receptors and/or catalytic properties, have been widely employed in biodetection platforms due to their beneficial properties. Like antibodies, aptamers have served as artificial target receptors in affinity biosensors. Currently, advanced biosensors with improved sensitivity and specificity are fabricated by the synergistic combination of aptamers and diverse nanomaterials. Herein, we review the current development and applications of nanomaterial-based aptasensors for the recognition of CVD biomarkers with special emphasis on electrochemical and optical technologies. The performance of aptasensors has been assessed further in terms of key quality assurance metrics along with discussions on recent technologies developed for the amplification of signals with enhanced portability.

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology